The first round of voting for STAT Madness began today. Included in the first round is the BIDMC team, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), who in collaboration with Johnson & Johnson developed and conducted preclinical testing of a single-dose COVID-19 vaccine, which is one of three COVID-19 vaccines cleared for emergency use in the U.S.

STAT Madness has begun. Vote for the best innovations in biomedicine

FDA issues emergency use authorization for Johnson & Johnson vaccine

Medical experts on Friday unanimously recommended that...

The Johnson & Johnson vaccine, which was developed in collaboration with BIDMC, was authorized Saturday for use in the U.S. Experts in gene-based technology, including Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC), produced a class of vaccines they believe can protect against all manner of outbreaks in the years to come.

Covid-19 Vaccines Yield Breakthroughs in Long-Term Fight Against Infectious Disease

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) led the team that developed the vaccine in a collaboration between Johnson & Johnson and BIDMC, and shared what its approval will mean for the state of Massachusetts’s vaccination efforts.

Johnson & Johnson Vaccine ‘Particularly Good For Mass Vaccination Campaigns,’ Boston Doctor Says

According to new trial data, Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than initially reported. The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).

What the latest Johnson & Johnson COVID vaccine data really means

Kevin Tabb, MD (CEO, BILH) joined leadership from local hospitals on the ‘Future of Health Care’ panel and noted health care is moving beyond the four walls of a hospital to any place it’s needed including physician’s offices, community health centers, or a patient’s home.

'Future of Health Care' panel: Pandemic drives system integration, anti-racism efforts

According to new trial data, Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than initially reported. The vaccine was developed in a collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).

New analyses show Johnson & Johnson’s one-dose vaccine works well.

A research team at BIDMC led by James E. Kirby, MD (Clinical Microbiology, BIDMC) and Ramy Arnaout, MD (Clinical Microbiology, BIDMC) has developed a mathematical model to estimate the false negative rate for COVID-19 tests.

Beth Israel Deaconess researchers build tool to estimate false negative COVID-19 test rates

BIDMC researchers build tool to estimate false negative COVID-19 test rates

A research team at BIDMC led by James E. Kirby...